Pharmaceutical company in
Steinhausen

Bristol-Myers Squibb Products SA

Since 1977 · 21–50 empl.·4.0(69)

Bristol-Myers Squibb Products SA is a biopharmaceutical company engaged in the research, development and provision of medicines. The company works in therapeutic areas including oncology, hematology, immunology and cardiovascular disease.

Lipoid AG

Since 1995 · 21–50 empl.

The core activity of Lipoid GmbH is the development, manufacture and distribution of pharmaceutical active ingredients, in particular phospholipids, as well as cosmetics and dietary supplements. The company offers a wide range of products, including parenteral, oral, topical, pulmonary and ocular applications, Active Pharmaceutical Ingredients (API), health and nutrition products, as well as cosmetics and skin care products.

NEURIM PHARMACEUTICALS AG

Since 1999 · 1–10 empl.

The core activity of Neurim Pharmaceuticals is the discovery and development of innovative medications for the treatment of central nervous system (CNS) disorders, with the goal of improving the lives of patients with unmet medical needs.

Bristol-Myers Squibb SA

Since 2002 · 21–50 empl.

Bristol-Myers Squibb SA is a global biopharmaceutical company that discovers, develops and delivers medicines for serious diseases. It conducts research and development, runs clinical trials and commercializes treatments in areas such as oncology, HIV and cardiovascular disease.

PTC Therapeutics Switzerland GmbH

Since 2014 · 21–50 empl.

The company's core activity is the development, manufacture and marketing of medicines for rare diseases. The company focuses on the discovery, development and global marketing of clinically differentiated medicines for patients with rare diseases.

BIOGRUND International AG

Since 2017 · 11–20 empl.

BIOGRUND International AG develops and manufactures excipient premixes for solid oral dosage forms. It offers ready-to-use systems for film coating, tableting, capsule filling, sugar coating and coloring for the pharmaceutical, nutraceutical and cosmetics industries.

Dayton Therapeutics AG

Since 2020 · 1–10 empl.

The core activity of Dayton Therapeutics AG is the development and application of therapeutics, particularly in the field of oncology, using digital and artificial intelligence technologies. The company is also active in investing in and advising life science companies, particularly in the areas of biotechnology and medical technology.

Ayus Medical Devices AG

Since 2023 · 1–10 empl.

QIAGEN Steinhausen AG

Since 2025 · 1–10 empl.

QIAGEN Steinhausen AG provides products and solutions for molecular biology, diagnostics, and laboratory automation. The website specifically references ordering in Switzerland, technical support, and customer service.

T-Oncology AG

Since 2022 · 1–10 empl.

T-Oncology AG works in the field of cancer therapies. Its website states an aim of reducing the fear associated with a metastasis diagnosis.

Viatris Pharma GmbH

Since 2014 · 101–500 empl.·2.1(9)

Viatris Pharma GmbH is a pharmaceutical company that develops, manufactures and markets branded medicines, generics and over‑the‑counter products. The company supplies a broad portfolio across multiple therapeutic areas and focuses on improving patient access to established medicines.

PETMedical AG

Since 2009 · 1–10 empl.